首页 | 本学科首页   官方微博 | 高级检索  
检索        

骨髓间充质干细胞移植后的肝功能重建
引用本文:刘芳,陈少红,刘青波,范新娟,唐芳,赵国强.骨髓间充质干细胞移植后的肝功能重建[J].中国神经再生研究,2011,15(10):1803-1808.
作者姓名:刘芳  陈少红  刘青波  范新娟  唐芳  赵国强
作者单位:南华大学医学院病理学教研室,肿瘤细胞与分子病理学湖南省高校重点实验室,湖南省衡阳市,中山大学中山医学院病理学教研室,中山大学附属第一医院病理科,广东省广州市 510080,中山大学中山医学院病理学教研室,中山大学附属第一医院病理科,广东省广州市 510080,中山大学中山医学院病理学教研室,中山大学附属第一医院病理科,广东省广州市 510080,中山大学中山医学院病理学教研室,中山大学附属第一医院病理科,广东省广州市 510080,中山大学中山医学院病理学教研室,中山大学附属第一医院病理科,广东省广州市 510080
基金项目:国家自然科学基金资助(30170473),广东省自然科学基金资助(04009326),湖南省教育厅课题资助( 08C744),湖南省高校重点实验室资助(09K074,09K075)。
摘    要:背景:细胞移植是治疗肝功能衰竭的一种有效方法,而理想的细胞源和最佳的移植途径一直是各实验室不断研究的目标。 目的:观察骨髓间充质干细胞移植对急性肝衰竭大鼠肝功能重建的影响和最佳移植途径。 方法:以D-氨基半乳糖胺作为肝脏毒剂,构建雌性SD大鼠急性肝衰竭模型。以雄性SD大鼠骨髓间充质干细胞为细胞源,通过腹股沟静脉和脾内移植两种途径植入肝衰竭大鼠,动态检测多项肝功能血生化指标。并以sry基因为分子标志,采用PCR技术检测骨髓间充质干细胞在肝脏内的存活状态。 结果与结论:骨髓间充质干细胞经腹股沟静脉和脾内移植均可降低血清谷丙转氨酶、谷草转氨酶、总胆红素水平,提高白蛋白合成能力,改善肝功能,降低动物死亡率。经腹股沟静脉移植组死亡率低于经脾内移植组。移植后7~30 d在受体大鼠肝脏内均能检测到sry基因阳性细胞的存在,而相应对照组未能检测到sry基因阳性细胞。结果表明①骨髓间充质干细胞移植可改善急性肝衰竭大鼠的肝功能。②骨髓间充质干细胞可在受体肝脏内存活。③经腹股沟静脉移植操作简便易行,死亡率较低,是较好的细胞移植途径

关 键 词:肝衰竭  细胞移植  骨髓间充质干细胞  腹股沟静脉移植  脾内移植

Reconstruction of hepatic functions after bone marrow mesenchymal stem cells transplantation
Liu Fang,Chen Shao-hong,Liu Qing-bo,Fan Xin-juan,Tang Fang and Zhao Guo-qiang.Reconstruction of hepatic functions after bone marrow mesenchymal stem cells transplantation[J].Neural Regeneration Research,2011,15(10):1803-1808.
Authors:Liu Fang  Chen Shao-hong  Liu Qing-bo  Fan Xin-juan  Tang Fang and Zhao Guo-qiang
Institution:Department of Pathology, University of South China Medical College; University Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan province, Hengyang 421001, Hunan Province, China,Department of Pathology, Zhongshan School of Medicine, Sun Yat-sen University; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China,Department of Pathology, Zhongshan School of Medicine, Sun Yat-sen University; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China,Department of Pathology, Zhongshan School of Medicine, Sun Yat-sen University; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China,Department of Pathology, Zhongshan School of Medicine, Sun Yat-sen University; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China,Department of Pathology, Zhongshan School of Medicine, Sun Yat-sen University; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
Abstract:BACKGROUND: Cell transplantation is an effective method for the treatment of hepatic function failure. However, ideal cell source and the best way to transplant has been the target of the ongoing research in laboratories. OBJECTIVE: To observe the effect and optimal transplantation way of bone marrow mesenchymal stem cells (BMSCs) transplantation on hepatic function reconstruction with acute hepatic failure in rats. METHODS: D-galactosamine (D-gal) was served as hepatic toxic agent, female SD rats with acute hepatic failure model was constructed. Male rats BMSCs as cell source was implanted hepatic failure rats through groin vein and intrasplenic transplantation. Many hepatic function blood biochemical indices were detected dynamically. Sry gene was served as molecule marker, the survival status of BMSCs in hepatic was detected by PCR technique. RESULTS AND CONCLUSION: BMSCs through groin vein and intrasplenic transplantation can lower the levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL), improve the ability of albumin (ALB) synthesis, ameliorate hepatic function, and reduce the death rate of acute hepatic failure rats. The death rate in the group of groin venous transplantation was lower than that in the intraspleen transplantation group. Sry gene positive cell was detected in hepatic of receptor rats at 7-30 days after transplantation; however, sry gene positive cell was not detected in hepatic of receptor rats in corresponding control group. The results showed that BMSCs can ameliorate hepatic function of acute hepatic failure rats. BMSCs can survive in the hepatic of receptor rats. The operation of groin venous transplantation is simple and convenient; the death rate is lower. So groin venous transplantation is a better way to treat acute hepatic failure rats.
Keywords:bone marrow mesenchymal stem cell  hepatic failure  cell transplantation
点击此处可从《中国神经再生研究》浏览原始摘要信息
点击此处可从《中国神经再生研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号